FDA NDC Directory · JSON-LD · Markdown
NDC 0472-2002 · HUMAN PRESCRIPTION DRUG · SUSPENSION
| Labeler / Manufacturer | Actavis Pharma, Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA074978 |
| Dosage form / route | SUSPENSION · ORAL |
| Active ingredients | IBUPROFEN (100 mg/5mL) |
| Marketing started | 20180716 |
| Package count | 2 |
Source: openFDA. Public-domain (CC0).